Lev-Ran Oren, Mohr Rephael, Pevni Dmitri, Nesher Nahum, Weissman Yona, Loberman Dan, Uretzky Gideon
Department of Cardiothoracic Surgery, Tel Aviv Sourasky Medical Center, Israel.
J Thorac Cardiovasc Surg. 2004 Apr;127(4):1145-50. doi: 10.1016/j.jtcvs.2003.10.012.
Despite potential long-term benefits, bilateral internal thoracic artery grafting in diabetics remains controversial because of the risk of sternal infection. We sought to assess the short- and long-term outcome after left-sided bilateral internal thoracic artery grafting and to determine the configuration of choice in diabetic subsets.
Between 1996 and 2001, 515 diabetics underwent isolated left-sided skeletonized bilateral internal thoracic artery grafting. The outcome of 468 consecutive oral-treated diabetics and 47 selective insulin-treated patients was analyzed. Patients undergoing T-grafting were compared with those undergoing in situ bilateral internal thoracic artery arrangements.
The respective rates for early mortality and sternal infections were 2.4% and 1.9% in oral-treated diabetics and 6.3% and 4.3% in insulin-treated diabetics. Multivariate correlates of sternal infection were chronic lung disease (odds ratio, 10), obesity (odds ratio, 7), reoperation (odds ratio, 22), and a creatinine level of 2 mg/dL or more (odds ratio, 8). Five-year survival was 82%. The T-graft (n = 437) and in situ (n = 162) subgroups had comparable baseline profiles. Freedom from cardiac mortality at 6.5 years was 95.6% and 87.6% (P =.277), and freedom from repeat revascularization was 91.5% and 92.7% (P =.860), respectively. The choice of bilateral internal thoracic artery configuration did not appear as a correlate of mortality, cardiac mortality, or major adverse cardiac events. Complementary right-sided gastroepiploic artery (hazard ratio, 0.36) and sequential (hazard ratio, 0.55) grafting were identified as protective factors against the occurrence of major adverse cardiac events.
Routine skeletonized bilateral internal thoracic artery grafting can be implemented safely in oral-treated diabetics. This strategy is associated with a favorable late cardiac outcome and is thus recommended. Both left-sided bilateral internal thoracic artery configurations provide comparable short- and long-term outcomes.
尽管双侧胸廓内动脉移植可能带来长期益处,但由于存在胸骨感染风险,糖尿病患者的双侧胸廓内动脉移植仍存在争议。我们旨在评估左侧双侧胸廓内动脉移植后的短期和长期结果,并确定糖尿病亚组中首选的术式。
1996年至2001年间,515例糖尿病患者接受了孤立的左侧骨骼化双侧胸廓内动脉移植。分析了468例连续口服治疗的糖尿病患者和47例选择性胰岛素治疗患者的结果。将接受T形移植的患者与接受原位双侧胸廓内动脉排列的患者进行比较。
口服治疗的糖尿病患者早期死亡率和胸骨感染率分别为2.4%和1.9%,胰岛素治疗的糖尿病患者为6.3%和4.3%。胸骨感染的多因素相关因素为慢性肺病(比值比,10)、肥胖(比值比,7)、再次手术(比值比,22)和肌酐水平≥2mg/dL(比值比,8)。五年生存率为82%。T形移植组(n = 437)和原位组(n = 162)的基线特征具有可比性。6.5年时无心脏死亡生存率分别为95.6%和87.6%(P = 0.277),无再次血运重建生存率分别为91.5%和92.7%(P = 0.860)。双侧胸廓内动脉术式的选择似乎与死亡率、心脏死亡率或主要不良心脏事件无关。右侧胃网膜动脉(风险比,0.36)和序贯(风险比,0.55)移植被确定为预防主要不良心脏事件发生的保护因素。
常规骨骼化双侧胸廓内动脉移植可在口服治疗的糖尿病患者中安全实施。该策略与良好的晚期心脏结局相关,因此推荐使用。两种左侧双侧胸廓内动脉术式的短期和长期结果相当。